Form 4: Liquidia Corp's Chief Medical Officer Rajeev Saggar Reports Stock Sale to Cover Taxes
SEC Form 4 Filing
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, sold shares of common stock to cover taxes associated with the settlement of restricted stock units.
Summary
- On October 14, 2024, Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reported a transaction involving the sale of 2,260 shares of Liquidia Corp common stock.
- The sale was executed at a price of $11.1077 per share.
- This transaction was made pursuant to a Rule 10b5-1 plan adopted on December 15, 2023.
- The shares were sold to cover taxes associated with the settlement of restricted stock units (RSUs) granted on January 11, 2023.
- Following the reported transaction, Saggar beneficially owns 207,383 shares of Liquidia Corp.
- This total includes unvested RSUs from grants made on July 18, 2022, January 11, 2023, and January 11, 2024, as well as shares acquired under the Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it doesn't indicate a particularly positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The sale of shares by a company officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale and the existence of a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| 2022-07-18 | Date of RSU grant to the Reporting Person. |
| 2023-01-11 | Date of RSU grant to the Reporting Person. |
| 2023-12-15 | Date the Reporting Person adopted the Rule 10b5-1 plan. |
| 2024-01-11 | Date of RSU grant to the Reporting Person. |
| 2024-10-14 | Date of the stock sale transaction. |
| 2024-10-15 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.